reported full-year worldwide revenue of about $65 billion in 2025, with Keytruda (pembrolizumab)/Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) sales amounting to roughly $31.7 billion and continuing to be the companys dominant growth engine, alongside contributions from pulmonary arterial hypertension (PAH) drug Winrevair (sotatercept-csrk), pneumonia vaccine Capvaxive (neumococcal 21-valent conjugate vaccine) and animal health products
"As mental health is now the most common reason people are on sick leave, or absent from work due to ill health, this has major implications for public health." Taylor added that, "this is a strong suggestion that they could be considered as treatments for depression or anxiety in the diabetic or obese populations." 'Quite strong' The researchers couldn't say precisely why the mental health benefits occurred Still, research director Docent Markku Lhteenvuo from the University of Eastern Finland said that the association "was quite strong." "It is possible that, in addition to factors such as reduced alcohol consumption, weight loss-related improvements in body image, or relief associated with better glycemic control in diabetes, there may also be direct neurobiological mechanisms involved, for example, through changes in the functioning of the brains reward system, Lhteenvuo said in the release
To achieve maximum effect with safety, maintain regular checkups and follow the doctors advice
[DOI] [PMC free article] [PubMed] [Google Scholar] 21.Witschi A., Reddy S., Stofer B., Lauterburg B.H
